Abstract
This study addressed the clinical characteristics, treatment, and outcome of middle ear cancer. A series of 33 patients with middle ear cancer were analyzed with survival, the primary outcome. Altogether, 25 patients underwent surgery with adjuvant radiotherapy, seven patients had surgery alone, and one patient had only radiotherapy. The patients were staged according to the Stell staging system. Among patients with T1/T2 cancers, five underwent lateral temporal bone resection (LTBR) and three underwent subtotal temporal bone resection (STBR). Among those with T3/Tx cancers, 11 underwent LTBR, and 13 had STBR. Of the total 33 patients, 18 died of their disease during follow-up. The overall 5-year survival rate was 37.4 %. The 5-year survival rates for patients with T1/T2 disease and T3/Tx disease were 85.7 and 22.0 %, respectively. There was a statistically significant difference in 5-year survival rates between the two groups using the log-rank test (P < 0.05). The 5-year survival rates after LTBR and STBR for the T3/Tx group were 15.2 and 30.8 % (P > 0.05), respectively, and those for the T1/T2 group were 100 and 66.7 % (P > 0.05), respectively. The 5-year survival rates for patients who underwent preoperative or postoperative radiotherapy were 38.9 and 40.4 %, respectively (P > 0.05). En bloc resection is favored in an effort to produce negative surgical margins for middle ear cancer. Adjunctive radiotherapy is used for advanced lesions.
Similar content being viewed by others
References
Moore MG, Deschler DG, McKenna MJ, Varvares MA, Lin DT (2007) Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies. Otolaryngol Head Neck Surg 137:893–898
Madsen AR, Gundgaard MG, Hoff CM et al (2008) Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001. Head Neck 10:1332–1338
Torske KR, Thompson LD (2002) Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 15:543–555
Nakagawa T, Kumamoto Y, Natori Y et al (2006) Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin. Otol Neurotol 27:242–248 discussion 249
Ogawa K, Nakamura K, Hatano K et al (2007) Treatment and prognosis of squamous cell carcinoma of the external auditory canal and middle ear: a multi-institutional retrospective review of 87 patients. Int J Radiat Oncol Biol Phys 68:1326–1334
Manolidis S, Pappas D Jr, Von Doersten P, Jackson CG, Glasscock ME III (1998) Temporal bone and lateral skull base malignancy: experience and results with 81 patients. Am J Otol 19:S1–S15
Moody SA, Hirsch BE, Myers EN (2000) Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol 21:582–588
Stell PM, McCormick MS (1985) Carcinoma of the external auditory meatus and middle ear. Prognostic factors and a suggested staging system. J Laryngol Otol 99:847–850
Austin JR, Stewart KL, Fawzi N (1994) Squamous cell carcinoma of the external canal: therapeutic prognosis based on a proposed staging system. Arch Otolaryngol Head Neck Surg 120:1228–1232
Tucker WN (1965) Cancer of the middle ear; A review of 89 cases. Cancer 18:642–650
Gurgel RK, Karnell LH, Hansen MR (2009) Middle ear cancer: a population-based study. Laryngoscope 119:1913–1917
Leonetti JP, Smith PG, Kletzker GR, Izquierdo R (1996) Invasion patterns of advanced temporal bone malignancies. Am J Otol 17:438–442
Pensak ML, Gleich LL, Gluckman JL, Shumrick KA (1996) Temporal bone carcinoma: contemporary perspectives in the skull base surgical era. Laryngoscope 106:1234–1237
Marur S, Forastiere AA (2008) Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 83:489–501
Devaney KO, Boschman CR, Willard SC, Ferlito A, Rinaldo A (2005) Tumours of the external ear and temporal bone. Lancet Oncol 6:411–420
Rothschild S, Ciernik IF, Hartmann M, Schuknecht B, Lutolf UM, Huber AM (2009) Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor. Am J Otol 30:256–260
Okada T, Saito K, Takahashi M et al (2008) En bloc petrosectomy for malignant tumors involving the external auditory canal and middle ear: surgical methods and long-term outcome. J Neurosurg 108:97–104
Moffat DA, Wagstaff SA, Hardy DG (2005) The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone. Laryngoscope 115:341–347
Chi FL, Gu FM, Dai CF, Chen B, Li HW (2011) Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone. Otol Neurotol 32:664–669
Sataloff RT, Myers DL, Lowry LD, Spiegel JR (1987) Total temporal bone resection for squamous cell carcinoma. Otolaryngol Head Neck Surg 96:4–14
Pemberton LS, Swindell R, Sykes AJ (2006) Primary radical radiotherapy for squamous cell carcinoma of the middle ear and external auditory canal: an historical series. Clin Oncol (R Coll Radiol) 18:390–394
Birzgalis AR, Keith AO, Farrington WT (1992) Radiotherapy in the treatment of middle ear and astoid carcinoma. Clin Otolaryngol Allied Sci 17:113–116
Cristalli G, Manciocco V, Pichi B et al (2009) Treatment and outcome of advanced external auditory canal and middle ear squamous cell carcinoma. J Craniofac Surg 20:816–821
Kunst H, Lavieille JP, Marres H (2008) Squamous cell carcinoma of the temporal bone: results and management. Otol Neurotol 29:549–552
Bibas AG, Ward V, Gleeson MJ (2008) Squamous cell carcinoma of the temporal bone. J Laryngol Otol 122:1156–1161
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jia, X., Liang, Q. & Chi, F. Treatment and outcome of middle ear cancer. Eur Arch Otorhinolaryngol 271, 2675–2680 (2014). https://doi.org/10.1007/s00405-013-2728-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-013-2728-1